These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 6214361)

  • 1. A partially degraded form of human plasminogen in circulating blood.
    Yamamoto J; Okamoto U; Kojima S; Morita S; Fujii K
    Clin Lab Haematol; 1982; 4(2):117-30. PubMed ID: 6214361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of the modified form of human plasminogen in the plasma activated by urokinase.
    Yamamoto J; Okamoto U; Morita S; Kikui K; Fujii Y
    Jpn J Physiol; 1983; 33(3):469-84. PubMed ID: 6226815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions.
    Wu JH; Diamond SL
    Thromb Haemost; 1995 Aug; 74(2):711-7. PubMed ID: 8585011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of histidine-rich glycoprotein (HRG) function via plasmin-mediated proteolytic cleavage.
    Poon IK; Olsson AK; Hulett MD; Parish CR
    Biochem J; 2009 Oct; 424(1):27-37. PubMed ID: 19712047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incorporation of fragment X into fibrin clots renders them more susceptible to lysis by plasmin.
    Schaefer AV; Leslie BA; Rischke JA; Stafford AR; Fredenburgh JC; Weitz JI
    Biochemistry; 2006 Apr; 45(13):4257-65. PubMed ID: 16566600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysfunctional plasminogen in full term newborn--study of active site of plasmin.
    Benavent A; Estellés A; Aznar J; Martinez-Sales V; Gilabert J; Fornas E
    Thromb Haemost; 1984 Feb; 51(1):67-70. PubMed ID: 6232730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for a role of the plasminogen activator--plasmin system in corneal ulceration.
    Berman M; Leary R; Gage J
    Invest Ophthalmol Vis Sci; 1980 Oct; 19(10):1204-21. PubMed ID: 6252112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane.
    Liotta LA; Goldfarb RH; Brundage R; Siegal GP; Terranova V; Garbisa S
    Cancer Res; 1981 Nov; 41(11 Pt 1):4629-36. PubMed ID: 6458354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Turnover of fibrinogen, plasminogen, and prothrombin during exercise in man.
    Collen D; Semeraro N; Tricot JP; Vermylen J
    J Appl Physiol Respir Environ Exerc Physiol; 1977 Jun; 42(6):865-73. PubMed ID: 142076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.
    Munkvad S
    Dan Med Bull; 1993 Sep; 40(4):383-408. PubMed ID: 8222763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assay of functional plasminogen in rat plasma applicable to experimental studies of thrombolysis.
    Bangert K; Thorsen S
    Thromb Haemost; 2000 Aug; 84(2):299-306. PubMed ID: 10959704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the purification and characterization of human urinary plasminogen and plasmin.
    Chen HF; Nakabayashi M; Satoh K; Sakamoto S
    Thromb Haemost; 1980 Feb; 42(5):1536-47. PubMed ID: 6445089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rate of activation and electrophoretic mobility of unmodified and partially degraded plasminogen. Effects of 6-aminohexanoic acid and related compounds.
    Thorsen S; Müllertz S
    Scand J Clin Lab Invest; 1974 Oct; 34(2):167-76. PubMed ID: 4278395
    [No Abstract]   [Full Text] [Related]  

  • 14. Fibrinolysis in health and disease: severe abnormalities in systemic lupus erythematosus.
    Glas-Greenwalt P; Kant KS; Allen C; Pollak VE
    J Lab Clin Med; 1984 Dec; 104(6):962-76. PubMed ID: 6239000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multimolecular form of human plasminogen in individual subjects.
    Yamamoto J; Okamoto U; Takenouchi J
    Nihon Ketsueki Gakkai Zasshi; 1984 Feb; 47(1):178-84. PubMed ID: 6741431
    [No Abstract]   [Full Text] [Related]  

  • 16. Functional hierarchy of plasminogen kringles 1 and 4 in fibrinolysis and plasmin-induced cell detachment and apoptosis.
    Ho-Tin-Noé B; Rojas G; Vranckx R; Lijnen HR; Anglés-Cano E
    FEBS J; 2005 Jul; 272(13):3387-400. PubMed ID: 15978044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation of a novel streptokinase mutant with improved stability.
    Shi GY; Chang BI; Su SW; Young KC; Wu DH; Chang LC; Tsai YS; Wu HL
    Thromb Haemost; 1998 May; 79(5):992-7. PubMed ID: 9609235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The interaction of human alpha 1-antitrypsin with human plasmin].
    Sakurama S
    Hokkaido Igaku Zasshi; 1984 Jan; 59(1):48-58. PubMed ID: 6232193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The plasminogen-plasmin system. 8. On the mechanism of chemical induction of fibrinolysis. Isolation of a latent plasminogen activator from human plasma.
    Tomikawa M; Abiko Y
    Thromb Diath Haemorrh; 1973 Feb; 29(1):50-62. PubMed ID: 4267738
    [No Abstract]   [Full Text] [Related]  

  • 20. The solution phase interaction between apolipoprotein(a) and plasminogen inhibits the binding of plasminogen to a plasmin-modified fibrinogen surface.
    Sangrar W; Gabel BR; Boffa MB; Walker JB; Hancock MA; Marcovina SM; Horrevoets AJ; Nesheim ME; Koschinsky ML
    Biochemistry; 1997 Aug; 36(34):10353-63. PubMed ID: 9265615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.